AUPH: Aurinia Pharmaceuticals Inc Stocks News on December 18, 2024

Exploring Three High Growth Tech Stocks In The United States

AUPH

Simply Wall St.

7 days ago

Exploring Three High Growth Tech Stocks In The United States

AUPH

Zacks

8 days ago

Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

AUPH

MT Newswires

9 days ago

Aurinia Pharmaceuticals Insider Bought Shares Worth $10,822,000, According to a Recent SEC Filing

AUPH

Simply Wall St.

12 days ago

While institutions own 40% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), retail investors are its largest shareholders with 52% ownership

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

AUPH

Business Wire

a month ago

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

AUPH

Business Wire

a month ago

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024

Aurinia to Participate in Jefferies London Healthcare Conference

AUPH

Business Wire

a month ago

Aurinia to Participate in Jefferies London Healthcare Conference

AUPH

MT Newswires

a month ago

RBC Adjusts Aurinia Pharmaceuticals' Price Target to $9 From $8, Keeps Outperform Speculative Risk Rating

Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets

AUPH

Pharmaceutical Technology

a month ago

Aurinia slashes workforce by 45% to focus on lupus and autoimmune assets

Aurinia Pharmaceuticals Reports Strong Q3 Growth and Restructuring

AUPH

TipRanks

a month ago

Aurinia Pharmaceuticals Reports Strong Q3 Growth and Restructuring

AUPH

GuruFocus.com

a month ago

Aurinia Pharmaceuticals Inc (AUPH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

AUPH

MT Newswires

a month ago

Aurinia Pharmaceuticals Reports Q3 Beat, Plans to Cut Workforce by 45%; Shares Rise

AUPH

Zacks

a month ago

Aurinia Pharmaceuticals (AUPH) Q3 Earnings and Revenues Beat Estimates

AUPH

Associated Press Finance

a month ago

Aurinia: Q3 Earnings Snapshot

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

AUPH

Business Wire

a month ago

Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development

AUPH

Business Wire

a month ago

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development

AUPH

Simply Wall St.

2 months ago

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) are in the red if they invested three years ago

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024

AUPH

Business Wire

2 months ago

Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024

AUPH

Business Wire

2 months ago

Aurinia Presents New Data Highlighting Real-World Utilization and Value of LUPKYNIS® in Treating Lupus Nephritis at American Society of Nephrology Kidney Week 2024

AUPH

Simply Wall St.

3 months ago

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Could Be Less Than A Year Away From Profitability

AUPH

MT Newswires

3 months ago

Aurinia Pharmaceuticals Says Lupus Nephritis Treatment Gets Japan's Approval

Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis

AUPH

Business Wire

3 months ago

Aurinia Announces Japan Approval of LUPKYNIS® (Voclosporin) to Treat Lupus Nephritis

Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

AUPH

Business Wire

3 months ago

Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference

AUPH

GuruFocus.com

3 months ago

Significant Acquisition by TANG CAPITAL MANAGEMENT LLC in Aurinia Pharmaceuticals Inc

AUPH

Business Wire

3 months ago

Aurinia Announces Board Restructuring

Top High Growth Tech Stocks To Watch In September 2024

AUPH

Simply Wall St.

3 months ago

Top High Growth Tech Stocks To Watch In September 2024

Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases

AUPH

Clinical Trials Arena

3 months ago

Aurinia doses first subject in Phase Ia trial of AUR200 for autoimmune diseases

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

AUPH

Business Wire

3 months ago

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial

Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference

AUPH

Business Wire

4 months ago

Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference

AUPH

Simply Wall St.

4 months ago

We're Interested To See How Aurinia Pharmaceuticals (NASDAQ:AUPH) Uses Its Cash Hoard To Grow

AUPH

Zacks

4 months ago

Do Options Traders Know Something About Aurinia (AUPH) Stock We Don't?

Aurinia Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations

AUPH

Simply Wall St.

4 months ago

Aurinia Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations

AUPH

Zacks

5 months ago

Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates

AUPH

Associated Press Finance

5 months ago

Aurinia: Q2 Earnings Snapshot

Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results

AUPH

Business Wire

5 months ago

Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results

Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

AUPH

Business Wire

5 months ago

Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

AUPH

Zacks

5 months ago

Aurinia (AUPH) Soars 6.6%: Is Further Upside Left in the Stock?

Aurinia to Participate in Upcoming Investor Healthcare Conferences

AUPH

Business Wire

6 months ago

Aurinia to Participate in Upcoming Investor Healthcare Conferences

AUPH

Simply Wall St.

6 months ago

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) most popular amongst retail investors who own 54% of the shares, institutions hold 35%

AUPH

Zacks

6 months ago

Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?

Aurinia Announces 2024 Annual General Meeting Results

AUPH

Business Wire

6 months ago

Aurinia Announces 2024 Annual General Meeting Results

AUPH

Simply Wall St.

6 months ago

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO For Now

AUPH

Business Wire

6 months ago

Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

AUPH

Business Wire

6 months ago

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

Aurinia Provides Update on Proxy Statement

AUPH

Business Wire

6 months ago

Aurinia Provides Update on Proxy Statement

Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

AUPH

Business Wire

7 months ago

Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

AUPH

Simply Wall St.

7 months ago

Shareholders in Aurinia Pharmaceuticals (NASDAQ:AUPH) have lost 64%, as stock drops 9.5% this past week

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024

AUPH

Business Wire

7 months ago

Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

AUPH

Business Wire

7 months ago

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

AUPH

Zacks

7 months ago

How Much Upside is Left in Aurinia (AUPH)? Wall Street Analysts Think 96.51%

Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference

AUPH

Business Wire

7 months ago

Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference

AUPH

Insider Monkey

7 months ago

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript

AUPH

Zacks

8 months ago

Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates

AUPH

Associated Press Finance

8 months ago

Aurinia: Q1 Earnings Snapshot

Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results

AUPH

Business Wire

8 months ago

Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results

Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month

AUPH

Business Wire

8 months ago

Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness Month

The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program

AUPH

Business Wire

8 months ago

The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program

UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference

AUPH

Business Wire

8 months ago

UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024

AUPH

Business Wire

8 months ago

Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024

Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference

AUPH

Business Wire

8 months ago

Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference

AUPH

Simply Wall St.

8 months ago

When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?

11 Oversold Biotech Stocks To Buy Right Now

AUPH

Insider Monkey

9 months ago

11 Oversold Biotech Stocks To Buy Right Now

AUPH

Simply Wall St.

9 months ago

We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn

Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program

AUPH

Business Wire

10 months ago

Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program

AUPH

Business Wire

10 months ago

Aurinia to Participate in Upcoming Investor Healthcare Conferences

Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations

AUPH

Simply Wall St.

10 months ago

Aurinia Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations

AUPH

Insider Monkey

10 months ago

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2023 Earnings Call Transcript

AUPH

Zacks

10 months ago

Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates

AUPH

GuruFocus.com

10 months ago

Aurinia Pharmaceuticals Inc (AUPH) Announces Year-End Financial Results and Strategic Initiatives

AUPH

Associated Press Finance

10 months ago

Aurinia: Q4 Earnings Snapshot

AUPH

Reuters

10 months ago

UPDATE 2-Aurinia Pharma fails to sell itself; to stop trials, cut jobs, buy back shares

Aurinia to cut research after sale process fails to find a buyer

AUPH

BioPharma Dive

10 months ago

Aurinia to cut research after sale process fails to find a buyer

AUPH

Reuters

10 months ago

Aurinia to stop R&D on immunotherapies to focus on kidney disease drug

AUPH

Zacks

10 months ago

Aurinia Pharmaceuticals (AUPH) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024

AUPH

Business Wire

10 months ago

Aurinia Pharmaceuticals to Release 2023 Fourth Quarter and Full Year Financial and Operational Results on February 15, 2024

Delek US Holdings' Big Spring Refinery Selected by the Department of Energy for Carbon Capture Project

AUPH

PR Newswire

a year ago

Delek US Holdings' Big Spring Refinery Selected by the Department of Energy for Carbon Capture Project

Delek Logistics Partners LP's Dividend Analysis

AUPH

GuruFocus.com

a year ago

Delek Logistics Partners LP's Dividend Analysis

AUPH

Thomson Reuters StreetEvents

a year ago

Q3 2024 Dorian LPG Ltd Earnings Call

MSG ENTERTAINMENT AND SPHERE ENTERTAINMENT NAME LAURA FRANCO EXECUTIVE VICE PRESIDENT AND GENERAL COUNSEL

AUPH

PR Newswire

a year ago

MSG ENTERTAINMENT AND SPHERE ENTERTAINMENT NAME LAURA FRANCO EXECUTIVE VICE PRESIDENT AND GENERAL COUNSEL

GUESS Announces Grand Re-Opening at the Forum Shops at Caesars Palace in Las Vegas

AUPH

Business Wire

a year ago

GUESS Announces Grand Re-Opening at the Forum Shops at Caesars Palace in Las Vegas

Boot Barn (BOOT) Q3 Earnings Beat Estimates, Sales Rise Y/Y

AUPH

Zacks

a year ago

Boot Barn (BOOT) Q3 Earnings Beat Estimates, Sales Rise Y/Y

Boot Barn Holdings Inc (BOOT) Reports Mixed Q3 Fiscal 2024 Results Amid Retail Challenges

AUPH

GuruFocus.com

a year ago

Boot Barn Holdings Inc (BOOT) Reports Mixed Q3 Fiscal 2024 Results Amid Retail Challenges

Dorian LPG Ltd. Reports Substantial Earnings Growth in Q3 FY2024

AUPH

GuruFocus.com

a year ago

Dorian LPG Ltd. Reports Substantial Earnings Growth in Q3 FY2024

AUPH

Associated Press Finance

a year ago

Dorian LPG: Fiscal Q3 Earnings Snapshot

AUPH

Business Wire

a year ago

Dorian LPG Ltd. Announces Third Quarter Fiscal Year 2024 Financial Results

AUPH

Thomson Reuters StreetEvents

a year ago

Q4 2023 Navient Corp Earnings Call

Navient (NAVI) Misses on Q4 Earnings, Plans Strategic Actions

AUPH

Zacks

a year ago

Navient (NAVI) Misses on Q4 Earnings, Plans Strategic Actions

AUPH

Business Wire

a year ago

GICL Completes the Rollout of 10,000km of Fiber Optic Cables

StoneX Group Inc. to Announce 2024 Fiscal First Quarter Earnings on February 6, 2024

AUPH

GlobeNewswire

a year ago

StoneX Group Inc. to Announce 2024 Fiscal First Quarter Earnings on February 6, 2024

StoneX Becomes Abaxx Exchange’s First Clearing and Trading Member to Expand Market Offering

AUPH

GlobeNewswire

a year ago

StoneX Becomes Abaxx Exchange’s First Clearing and Trading Member to Expand Market Offering

5 Stocks Trading Near 52-Week High That Can Climb Further

AUPH

Zacks

a year ago

5 Stocks Trading Near 52-Week High That Can Climb Further

Dorian LPG (LPG) to Report Q3 Earnings: What's in Store?

AUPH

Zacks

a year ago

Dorian LPG (LPG) to Report Q3 Earnings: What's in Store?

Why Canadian Solar (CSIQ) Dipped More Than Broader Market Today

AUPH

Zacks

a year ago

Why Canadian Solar (CSIQ) Dipped More Than Broader Market Today

AUPH

Insider Monkey

a year ago

13 Best Utility Dividend Stocks To Buy

Innovative Industrial Properties (IIPR) Advances But Underperforms Market: Key Facts

AUPH

Zacks

a year ago

Innovative Industrial Properties (IIPR) Advances But Underperforms Market: Key Facts

California Water Service Group Board of Directors Declares 316th Consecutive Quarterly Dividend and 57th Consecutive Annual Dividend Increase

AUPH

GlobeNewswire

a year ago

California Water Service Group Board of Directors Declares 316th Consecutive Quarterly Dividend and 57th Consecutive Annual Dividend Increase

Columbia Financial (CLBK) Surpasses Q4 Earnings and Revenue Estimates

AUPH

Zacks

a year ago

Columbia Financial (CLBK) Surpasses Q4 Earnings and Revenue Estimates

Bowlero to Report Second Quarter 2024 Financial Results on February 5, 2024

AUPH

Business Wire

a year ago

Bowlero to Report Second Quarter 2024 Financial Results on February 5, 2024

Why this strategist thinks 2024 is year of the vanity trade

AUPH

Yahoo Finance Video

a year ago

Why this strategist thinks 2024 is year of the vanity trade

When Should You Buy MillerKnoll, Inc. (NASDAQ:MLKN)?

AUPH

Simply Wall St.

a year ago

Latest Aurinia Pharmaceuticals Inc (AUPH) News on December 18, 2024

Share on Social Networks: